Exchange: NASDAQ·Updated 12:00 AM EST

About LVTX

About

LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
34

Frequently Asked Questions

Advertisement|Remove ads.